Global Subdermal Contraceptive Implants Market Growth (Status and Outlook) 2023-2029

Global Subdermal Contraceptive Implants Market Growth (Status and Outlook) 2023-2029

Subdermal Contraceptive Implants are a long-term birth control option for women. A subdermal contraceptive implant is a flexible plastic rod about the size of a matchstick that is placed under the skin of the upper arm.

LPI (LP Information)' newest research report, the “Subdermal Contraceptive Implants Industry Forecast” looks at past sales and reviews total world Subdermal Contraceptive Implants sales in 2022, providing a comprehensive analysis by region and market sector of projected Subdermal Contraceptive Implants sales for 2023 through 2029. With Subdermal Contraceptive Implants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Subdermal Contraceptive Implants industry.

This Insight Report provides a comprehensive analysis of the global Subdermal Contraceptive Implants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Subdermal Contraceptive Implants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Subdermal Contraceptive Implants market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Subdermal Contraceptive Implants and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Subdermal Contraceptive Implants.

The global Subdermal Contraceptive Implants market size is projected to grow from US$ 635.8 million in 2022 to US$ 984.3 million in 2029; it is expected to grow at a CAGR of 6.4% from 2023 to 2029.

Increase in use of modern contraceptive methods, rising awareness about sexual health and family planning, and increase in government initiatives are likely to drive the market during the forecast period.

This report presents a comprehensive overview, market shares, and growth opportunities of Subdermal Contraceptive Implants market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Original
Generic

Segmentation by application
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer AG
Merck & Co. Inc.
Shanghai Dahua Pharmaceutical Co., Ltd.

Please note: The report will take approximately 2 business days to prepare and deliver.